Related Concepts
Related Feeds
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Related Papers
Anticancer Research
M KurokiT Yamamoto
American Journal of Clinical Pathology
L KassD Vugrin
The British Journal of Dermatology
R M GrahamE Heyderman
American Journal of Clinical Pathology
A E WaltsS Banks-Schlegel
Proceedings of the National Academy of Sciences of the United States of America
S von KleistP Burtin